Class Action Opportunity – Homology Medicines, Inc.
Homology Medicines, Inc. Investors with Substantial Losses Have Opportunity toRead More
Class Action Investigation & Lawsuit News
Homology Medicines, Inc. Investors with Substantial Losses Have Opportunity toRead More
The Samuel Law Firm Files Class Action Against Safety-Kleen Inc.Read More
Alnylam Pharmaceuticals Files Patent Infringement Suits against Pfizer and ModernaRead More
Baron & Budd Obtains Court Approval for $550 Million ClassRead More
NOTICE: Cabaletta Bio, Inc. Investors with Substantial Losses Have OpportunityRead More
RBB BANCORP ALERT: Bragar Eagel & Squire, P.C. is InvestigatingRead More
DOCUSIGN DEADLINE ALERT: Bragar Eagel & Squire, P.C. Reminds InvestorsRead More
CHGG DEADLINE TUESDAY: ROSEN, A TOP RANKED FIRM, Encourages Chegg,Read More
ARVL TUESDAY DEADLINE: ROSEN, RESPECTED INVESTOR COUNSEL, Encourages Arrival SARead More
SUNPOWER SHAREHOLDER ALERT by Former Louisiana Attorney General: Kahn SwickRead More
PLSE CLASS ACTION NOTICE: Glancy Prongay & Murray LLP FilesRead More
SHAREHOLDER ALERT – Labaton Sucharow Investigating Ericsson – ERIC NEWRead More